TW
ABBV icon

TritonPoint Wealth’s AbbVie ABBV Stock Holding History

TritonPoint Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.47M Sell
11,376
-722
-6% -$160K 0.26% 83
2025
Q4 		$2.76M Sell
12,098
-538
-4% -$123K 0.28% 83
2025
Q3 		$2.93M Buy
12,636
+220
+2% +$44.8K 0.25% 97
2025
Q2 		$2.3M Buy
12,416
+213
+2% +$39.6K 0.21% 108
2025
Q1 		$2.56M Buy
12,203
+830
+7% +$161K 0.24% 95
2024
Q4 		$2.02M Buy
11,373
+633
+6% +$116K 0.18% 116
2024
Q3 		$2.09M Buy
10,740
+697
+7% +$130K 0.19% 113
2024
Q2 		$1.72M Sell
10,043
-1,787
-15% -$296K 0.17% 118
2024
Q1 		$1.75M Sell
11,830
-1,134
-9% -$195K 0.18% 114
2023
Q4 		$2.01M Buy
+12,964
New +$1.89M 0.2% 111

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TritonPoint Wealth's ABBV Position: Q1 2026 in Review

TritonPoint Wealth reduced its AbbVie (ABBV) stake by 6% in Q1 2026, selling an estimated $160K and leaving 11,376 shares worth $2.47M. The position accounts for 0.26% of the portfolio, ranked #83.

TritonPoint Wealth first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.93M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TritonPoint Wealth held 11,376 shares of AbbVie worth $2.47M as of Q1 2026.
  • TritonPoint Wealth sold 722 AbbVie shares in Q1 2026, an estimated $160K.
  • AbbVie made up 0.26% of TritonPoint Wealth's portfolio in Q1 2026, its #83 holding.
  • TritonPoint Wealth first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • TritonPoint Wealth's AbbVie position peaked at $2.93M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TritonPoint Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.